Enter a new era of optical genome mapping: Register now for Symposium 2024!

Thank you for your interest in this workshop. Please fill in the form and submit to access the recording and discover how OGM benefits clinical research in cancer.

Optical Genome Mapping Meets Challenges for New Blood Cancer Classifications.


  • Adam Smith, PhD, FCCMG, FACMG | Director, Cancer Cytogenetic Laboratory and Clinician Investigator, University Health Network, Toronto
  • Alka Chaubey, PhD, FACMB | Chief Medical Officer, Bionano